Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer

Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer

NCT02530008 ·Status: ACTIVE_NOT_RECRUITING

Microbiome Immunotherapy Neoadjuvant Assessment

NCT06709651 ·Status: RECRUITING

Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients

NCT04145947 ·Status: UNKNOWN

Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer

NCT06418126 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

BRCA and NACT in TNBC Patients

NCT05750719 ·Status: COMPLETED

Biomarker Study of Breast Tumors

NCT00941408 ·Status: UNKNOWN

Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer

NCT04021069 ·Status: UNKNOWN

Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

NCT05528133 ·Status: RECRUITING ·Phase: PHASE2

Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma

NCT04365790 ·Status: UNKNOWN

Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Tumor Specimens in Breast Cancer

NCT01247480 ·Status: UNKNOWN

Prognostic Relevance of Biological Subtype in Breast Cancer

NCT02063906 ·Status: UNKNOWN

Neoadjuvant Chemotherapy Response in Metaplastic Carcinoma of Triple Negative Breast Cancer

NCT04549584 ·Status: TERMINATED

Development of Predictive Biomarkers and Novel Approached to Therapy in Breast Cancer

NCT01051492 ·Status: UNKNOWN

Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm

NCT02266420 ·Status: COMPLETED ·Phase: NA

Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile

NCT04250818 ·Status: SUSPENDED

Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging

NCT03568448 ·Status: ACTIVE_NOT_RECRUITING

VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study

NCT06409221 ·Status: ENROLLING_BY_INVITATION

Circulating Tumor DNA Monitoring in Breast Cancer Undergoing Neoadjuvant Therapy

NCT05649475 ·Status: UNKNOWN

Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer

NCT06879704 ·Status: RECRUITING ·Phase: NA

Comparison of the Breast Tumor Microenvironment

NCT03165487 ·Status: ACTIVE_NOT_RECRUITING

Use of INnovative and Micro-INvasive TEchniques for the Early Identification of Breast Cancer Patients Benefitting From Neo-adjuvant Therapy

NCT05846997 ·Status: UNKNOWN

Using of Costimulatory and co Inhibatory Immune Checkpoints as Diagnostic and Prognostic in Breast Cancer

NCT06169007 ·Status: NOT_YET_RECRUITING

S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil

NCT00897091 ·Status: COMPLETED

Study of Biomarkers in Tissue Samples From Patients With Breast Cancer

NCT01004796 ·Status: UNKNOWN

Triple Negative Breast Cancer: Study of Molecular and Genetic Factors

NCT01434420 ·Status: UNKNOWN ·Phase: NA